Layer 1
Mur zone | CPD (1969)

Refine

E.g., 03/06/2020
E.g., 03/06/2020
What pharmacists need to know about how COVID-19 testing is regulated
How is COVID-19 testing regulated?
03/06/2020 0 Unplanned learning
COVID-19 rapid Nice guideline summary: Immunocompromised children
Nice has published advice to maximise the safety of immunocompromised children and young people during the pandemic
28/05/2020 0 Unplanned learning
Will the pre-registration year be different post-pandemic?
C+D spoke to Regan McCahill, president of the British Pharmaceutical Students’ Association, on how COVID-19 has affected pre-reg students
28/05/2020 2 Podcast
Yellow card reporting during the COVID-19 pandemic
What adverse reactions should be reported for medicines and devices related to COVID-19 treatment?
21/05/2020 0 Unplanned learning
Medicine deliveries during lockdown
With prescription delivery services stretched during the COVID-19 pandemic, how can pharmacies continue to meet demand while also protecting the...
21/05/2020 3 Unplanned learning
What is the difference between vulnerable and shielding patients?
Dr Toni Hazell reveals what advice community pharmacists can give vulnerable patients who are not on the shielded list, such as those aged over 70
14/05/2020 0 Podcast
Pharmacy teams and personal protective equipment
When should personal protective equipment be worn in the pharmacy?
14/05/2020 0 Unplanned learning
Chloroquine, hydroxychloroquine and COVID-19
What is the latest advice for the use of chloroquine and hydroxychloroquine in the prevention or treatment of COVID-19?
06/05/2020 0 Unplanned learning
COVID-19 Nice guideline summary: Cystic fibrosis
Nice has published a rapid guideline for the care of patients with cystic fibrosis (CF) during the COVID-19 pandemic, including those with suspected...
06/05/2020 0 Unplanned learning
Podcast: Abuse against pharmacy teams during the COVID-19 pandemic
C+D spoke to Leyla Hannbeck about the impact of COVID-19 on community pharmacy
30/04/2020 0 Podcast

Pages